Cipla
Daljit Thaker is an accomplished finance professional with extensive experience in global financial planning and analysis, currently serving as Vice President and Head of Global FP&A at Cipla since February 2014. In this role, Daljit leads the financial planning and analysis function, develops financial models, manages budgeting processes, and collaborates with senior leadership to drive strategic decisions. Prior to this, Daljit held various key positions including Senior Director of Finance Shared Services at Cipla and roles at Cadbury plc, Essar Shared Service Center, WNS, Thomson Reuters, and Tracmail, demonstrating strong expertise in financial modeling, reporting, team leadership, and service delivery optimization. Daljit's skill set encompasses strategic thinking, collaboration, and effective communication, contributing to enhanced business decision-making and operational excellence.
This person is not in any teams
This person is not in any offices
Cipla
19 followers
Cipla is a pharmaceutical company. The Company's strategic business units include Active Pharmaceutical Ingredients (APIs), Respiratory and Cipla Global Access. The Company's geographical segments include India, USA, South Africa and Rest of the World. The Company manufactures metered dose inhalers, dry powder inhalers, nasal sprays, nebulizers and a range of inhaled accessory devices. Cipla Global Access is a tender-based institutional business that concentrates on approximately four therapy areas: human immunodeficiency virus/acquired immuno deficiency syndrome (HIV/AIDS), malaria, multi drug-resistant tuberculosis and reproductive health. The Company offers its products for the therapeutic areas, including cardiovascular, children's health, dermatology and cosmetology, diabetes, HIV/AIDS, infectious diseases and critical care, malaria, neurosciences, oncology, ophthalmology, osteoporosis, respiratory, urology and women's health.